Dr. Bhavana Konda
Claim this profileOhio State University Comprehensive Cancer Center
Area of expertise
Neuroendocrine Tumors
Bhavana Konda has run 4 trials for Neuroendocrine Tumors. Some of their research focus areas include:
Cancer
Bhavana Konda has run 3 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Ohio State University Comprehensive Cancer Center
Ohio State University Medical Center
Clinical Trials Bhavana Konda is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting
1 award
Phase 2 & 3
10 criteria
Radioactive Drug vs Everolimus
for Neuroendocrine Cancer
This phase II trial compares the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual approach of treatment with everolimus, sunitinib, or cabozantinib in patients who have previously received 177Lu-DOTATATE for gastroenteropancreatic neuroendocrine tumor (GEPNET) that has spread from where it first started (primary site) to other places in the body (metastatic) and that cannot be removed by surgery (unresectable). PRRT is a type of radiation therapy for which a radioactive chemical is linked to a peptide (small protein) that targets tumor cells. When this radioactive peptide is injected into the body, it binds to a specific receptor found on some tumor cells. The radioactive peptide builds up in these cells and helps kill the tumor cells without harming normal cells. In this trial 177Lu-DOTATATE is used for PRRT. 177Lu-DOTATATE PRRT may increase the length of time until worsening of the GEPNET compared to the usual approach. Everolimus is in a class of medications called kinase inhibitors. It is also a type of angiogenesis inhibitor. Everolimus works by stopping tumor cells from reproducing and by decreasing blood supply to the tumor cells. Sunitinib and cabozantinib, block certain proteins, which may help keep tumor cells from growing. They may also prevent the growth of new blood vessels that tumors need to grow. Sunitinib malate is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Retreating with 177Lu-DOTATATE may work better than everolimus, sunitinib or cabozantinib in shrinking or stabilizing tumors in patients with metastatic and unresectable GEPNET who were previously treated with 177Lu-DOTATATE.
Recruiting
1 award
Phase 2
More about Bhavana Konda
Clinical Trial Related
2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Bhavana Konda has experience with
- Lutetium Lu 177 Dotatate
- Cabozantinib S-malate
- Ipilimumab
- Nivolumab
- Cabozantinib
- Triapine
Breakdown of trials Bhavana Konda has run
Neuroendocrine Tumors
Cancer
Carcinoid Tumor
Papillary Thyroid Cancer
Thyroid Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bhavana Konda specialize in?
Bhavana Konda focuses on Neuroendocrine Tumors and Cancer. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Bhavana Konda currently recruiting for clinical trials?
Yes, Bhavana Konda is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Bhavana Konda has studied deeply?
Yes, Bhavana Konda has studied treatments such as Lutetium Lu 177 Dotatate, Cabozantinib S-malate, Ipilimumab.
What is the best way to schedule an appointment with Bhavana Konda?
Apply for one of the trials that Bhavana Konda is conducting.
What is the office address of Bhavana Konda?
The office of Bhavana Konda is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.